Israel Englander’s Procept Biorobotics PRCT Stock Holding History

Israel Englander’s Portfolio PRCT Stock Details PRCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-20,000	Closed	-$500K	–	6296
2026 Q1	$500K	Buy	+20,000	New	+$564K	﹤0.01%	4769
2024 Q4	–	Sell	-70,000	Closed	-$5.61M	–	6354
2024 Q3	$5.61M	Buy	70,000 +40,000	+133%	+$2.84M	﹤0.01%	2736
2024 Q2	$1.83M	Buy	30,000 +10,000	+50%	+$595K	﹤0.01%	3605
2024 Q1	$988K	Buy	+20,000	New	+$952K	﹤0.01%	4300
2023 Q4	–	Sell	-20,200	Closed	-$663K	–	6439
2023 Q3	$663K	Sell	20,200 -9,800	-33%	-$334K	﹤0.01%	4479
2023 Q2	$1.06M	Buy	+30,000	New	+$992K	﹤0.01%	3997
2022 Q3	–	Sell	-75,000	Closed	-$2.45M	–	7399
2022 Q2	$2.45M	Buy	+75,000	New	+$2.73M	﹤0.01%	3489

Other funds holding PRCT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Israel Englander's PRCT Position: Q2 2026 in Review

Israel Englander reduced its Procept Biorobotics (PRCT) stake by 38% in Q2 2026, selling an estimated $9.54M and leaving 624,312 shares worth $14.1M. The position accounts for 0.01% of the portfolio, ranked #1956.

Israel Englander first reported a position in PRCT in Q3 2021 and has held it in 16 quarters since. The position peaked at $31.6M in Q1 2025. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

Israel Englander held 624,312 shares of Procept Biorobotics worth $14.1M as of Q2 2026.
Israel Englander sold 381,146 Procept Biorobotics shares in Q2 2026, an estimated $9.54M.
Procept Biorobotics made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1956 holding.
Israel Englander first reported a position in Procept Biorobotics in Q3 2021 and has held it in 16 quarters since.
Israel Englander's Procept Biorobotics position peaked at $31.6M in Q1 2025.
253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.